Day One Biopharmaceuticals, a provider of targeted therapies for children and adults with cancer, has raised $130 million in Series B financing. RA Capital Management led the round.
Source: Press Release
Day One Biopharmaceuticals lands $130m Series B
Day One Biopharmaceuticals, a provider of targeted therapies for children and adults with cancer, has raised $130 million in Series B financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: